These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases. Mombelli G; Monotti R; Haeberli A; Straub PW Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428 [TBL] [Abstract][Full Text] [Related]
6. Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction. Eisenberg PR; Sherman LA; Perez J; Jaffe AS Thromb Res; 1987 Apr; 46(1):109-20. PubMed ID: 3590109 [TBL] [Abstract][Full Text] [Related]
7. Early risk stratification of unstable angina/non-Q myocardial infarction: biochemical markers of coronary thrombosis. Galvani M; Ferrini D; Ottani F; Eisenberg PR Int J Cardiol; 1999 Apr; 68 Suppl 1():S55-61. PubMed ID: 10328612 [TBL] [Abstract][Full Text] [Related]
8. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605 [TBL] [Abstract][Full Text] [Related]